Dementia Progression with GLP-1 Receptor Agonists in People with Type 2 Diabetes and Mild Cognitive Impairment: Retrospective Cohort Study

Related

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026

• GLP-1 agonists linked to lower dementia risk after COVID-19

  Drug Design, Development and Therapy · 5 Oct 2026

  

• COVID-19 tied to higher dementia risk in older adults with diabetes

  Frontiers in Aging Neuroscience · 4 Oct 2026

• GLP-1 receptor agonists link to lower stroke and Alzheimer risk

  Neurology Genetics · 4 Oct 2026